Sign up to save your podcasts
Or
Share Early calprotectin measurement to predict response to ustekinumab therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Early calprotectin measurement to predict response to ustekinumab therapy
Dr. Neeraj Narula reports a post-hoc analysis of the UNITI Crohn’s trials showing that early measurement of faecal calprotectin after induction therapy predicts clinical outcomes better than baseline measurements of calprotectin and than other week 6 clinical or biomarker data.
View all episodes
By Oxford University PressDr. Neeraj Narula reports a post-hoc analysis of the UNITI Crohn’s trials showing that early measurement of faecal calprotectin after induction therapy predicts clinical outcomes better than baseline measurements of calprotectin and than other week 6 clinical or biomarker data.